Shenzhen Drama Point Entertainment Culture Co., Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen Drama Point Entertainment Culture Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOUMODINE. The owner is based in Shenzhen.
Logistics Area,No.1 Ping'an AvePinghu St
13A08,Bldg.12,East China Railway
Shenzhen 518111 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Drama Point Entertainment Culture Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Drama Point Entertainment Culture Co., Ltd have?
Shenzhen Drama Point Entertainment Culture Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Shenzhen Drama Point Entertainment Culture Co., Ltd file in?
Shenzhen Drama Point Entertainment Culture Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Drama Point Entertainment Culture Co., Ltd's most well-known trademarks?
Shenzhen Drama Point Entertainment Culture Co., Ltd's registered trademark portfolio includes well-known marks such as SOUMODINE. These are among 1 currently registered trademark in the portfolio.
What is Shenzhen Drama Point Entertainment Culture Co., Ltd's trademark registration success rate?
Shenzhen Drama Point Entertainment Culture Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.